Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001062993-25-002175 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-02-12	2025-02-10	COLL	Kuhlmann Shirley R.	EVP, GC	F - Tax	$30.52	-35.0K	154.2K	-18%	-$1.07M
M	2025-02-12	2025-02-10	COLL	Kuhlmann Shirley R.	EVP, GC	A - Grant	$0.00	+70.0K	160.1K	+78%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-02-10	F	D	9,826	$30.52	179,353	D	—	—	(F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
2	Common	Common Stock	2025-02-10	F	D	25,149	$30.52	154,204	D	—	—	(F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
3	Common	Common Stock	2025-02-10	A	A	29,030	$0.00	189,179	D	—	—	(F2) Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 29,030 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
4	Common	Common Stock	2025-02-10	A	A	40,965	$0.00	160,149	D	—	—	(F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.